Allgemeine Stellungnahme der ZKBS zu häufig durchgeführten gentechnischen Arbeiten mit den zugrunde liegenden Kriterien der Vergleichbarkeit

Gentransfer mithilfe von Adenovirus Typ 5
Empfehlung des Robert Koch-Instituts


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The molecular biology of Adenoviruses (1983) Doerfler W (ed) Corrent topics in microbiology and immunology 109, 110, 111. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  2. 2.
    Fields BN, Knipe DM, Howley PM et al. (1996) Fields virology. Lippincott,PhiladelphiaGoogle Scholar
  3. 3.
    Murray JD, Bellett AJD, Braithwaite AW, Waldron LK, Taylor IW (1982) Altered cell cycle progression and aberrant mitosis in Adenovirus-infected rodent cells. J Cell Phys 111:89–96CrossRefGoogle Scholar
  4. 4.
    Braithwaite AW (1986) Semipermissive replication of Adenovirus type 5 in rat brain cells and evidence for an induction of cellular DNA replication in vivo. J Gen Virol 67:391–396PubMedCrossRefGoogle Scholar
  5. 5.
    Eggerding FA, Pierce WC (1986) Molecular biology of Adenovirus type 2 semipermissive infections. Virology 148:97–118PubMedCrossRefGoogle Scholar
  6. 6.
    Bridge E, Ketner G (1989) Redundant control of Adenovirus late gene expression by early region 4. J Virol 63:631–638PubMedCentralPubMedGoogle Scholar
  7. 7.
    Robbins PD, Tahara H, Ghivizzani SC (1998) Viral vectors for gene therapy. TibTech 16:35–40CrossRefGoogle Scholar
  8. 8.
    Xiang ZQ, Yang Y, Wilson JM, Ertl HC (1996) A replication-defective human Adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220–227PubMedCrossRefGoogle Scholar
  9. 9.
    Gluzman Y, Reichl H, Solnick D (1985) Helper-free Adenovirus type 5 vectors.Eucaryotic viral vectors. Cold Spring Harbor, New YorkGoogle Scholar
  10. 10.
    Ghosh-Choudhury G, Haj-Ahmad Y, Brinkley P, Rudy J, Graham FL (1986) Human Adenovirus cloning vectors based on infectious bacterial plasmids. Gene 50:161–171PubMedCrossRefGoogle Scholar
  11. 11.
    Benihoud K, Yeh P, Perricaudet M (1999) Adenovirus vectors for gene delivery. Curr Opin Biotechnol 10:440–447PubMedCrossRefGoogle Scholar
  12. 12.
    Vile RG, Russell SJ, Lemoine NR (2000) Cancer gene therapy: hard lessons and new courses. Gene Ther 1:2–8CrossRefGoogle Scholar
  13. 13.
    Bett AJ, Prevec L, Graham FL (1993) Packaging capacity and stability of human Adenovirus type 5 vectors. J Virol 67:5911–5921PubMedCentralPubMedGoogle Scholar
  14. 14.
    Graham FL, Smiley JS, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human Adenovirus Type 5. J Gen Virol 36:59–72PubMedCrossRefGoogle Scholar
  15. 15.
    Louis N, Evelegh C, Graham FL (1997) Cloning and sequencing of the cellular — viral junctions from the human Adenovirus Type 5 transformed 293 cell line. Virology 233:423–429PubMedCrossRefGoogle Scholar
  16. 16.
    Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, van Ormondt H, Hoeben RC, van der Eb AJ (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7:215–222PubMedCrossRefGoogle Scholar
  17. 17.
    Hanahan D (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166:557–580PubMedCrossRefGoogle Scholar
  18. 18.
    Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M (1996) Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70:4805–4810PubMedCentralPubMedGoogle Scholar
  19. 19.
    He TC, Zhou S, de Cost LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system,for generating recombinant adenoviruses. Proc Natl Acad Sci USA:2509–2514Google Scholar
  20. 20.
    Engelhardt JF, Simon RH, Yang Y et al. (1993) Adenovirus-mediadet transfer of the CFTR-gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther 4:759–769PubMedCrossRefGoogle Scholar
  21. 21.
    Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenovirus for gene therapy. Procc Natl Acad Sci USA 91:4407–4411CrossRefGoogle Scholar
  22. 22.
    Nelson JE, Kay MA (1997) Persistence of recombinant adenovirus in vivo is not dependent on vector replication. J Virol 71:8902–8907PubMedCentralPubMedGoogle Scholar
  23. 23.
    Goldsmith KT, Dion LD, Curiel DT, Garver RI Jr (1998) Trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus. Virology 248:406–419PubMedCrossRefGoogle Scholar
  24. 24.
    Steinwaerder DS, Carlson CA, Lieber A (2000) DNA replication of first-generation adenovirus vectors in tumor cells.Hum Gene Ther 11:1933–1948PubMedCrossRefGoogle Scholar
  25. 25.
    Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT (1996) A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length cystotrophin and β-Galaktosidase. Proc Nat.Acad Sci USA 93:5731–5736PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM (1996) Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11–22PubMedCrossRefGoogle Scholar
  27. 27.
    Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL (1996) A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 93:13565–13570PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Schiedner G, Morral N, Parks RJ et al.(1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180–183PubMedCrossRefGoogle Scholar
  29. 29.
    Kochanek S (1999) High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 10:2451–2459PubMedCrossRefGoogle Scholar
  30. 30.
    Lochmueller H, Jani A, Huard J et al. (1994) Emergence of early region 1-containing replicationcompetent adenovirus in stocks of replication-defective adenovirus recombinants (△E1+△E3) during multiple passages in 293 cells. Hum Gene Ther 5:1485–1491CrossRefGoogle Scholar
  31. 31.
    Zhang WW, Koch PE, Roth JA (1995) Detection of wildtype contamination in a recombinant adenoviral preparation by PCR. BioTechniques 18:444–447PubMedGoogle Scholar
  32. 32.
    Hehir KM, Armentano D, Cardoza LM et al. (1996) Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol 70:8459–8467PubMedCentralPubMedGoogle Scholar
  33. 33.
    Fallaux FJ, Bout A, van der Velde I et al. (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9:1909–1917PubMedCrossRefGoogle Scholar
  34. 34.
    Schiedner G, Hertel S, Kochanek S (2000) Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 11: 2105–2116PubMedCrossRefGoogle Scholar
  35. 35.
    Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birnstiel ML (1992) High-efficiency receptor-mediated delivery of small and large (48 Kb) gene constructs using the endosome-disrupting activity of chemically inactivated adenovirus particles.Proc Natl Acad Sci USA 80:5383–5386Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Personalised recommendations